Clinical Trial Update: A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612) [Phase 3]

View source ↗

Summary

This clinical trial update reports results from a Phase 3 study of infliximab in adults with moderate-to-severe psoriasis not responding to standard or biologic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2010-12-24